Germany· DE-A57-16b7cfeb4270fda1
Tranxilium
A medicinal product containing dipotassium clorazepate, registered in Germany by Neuraxpharm Arzneimittel Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Dipotassium Clorazepate
- Manufacturer
- Neuraxpharm Arzneimittel Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dipotassium clorazepate in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesClorazepate DipotassiumPD-Rx Pharmaceuticals, Inc.
- BelgiumTranxene 10 mgImpexeco
- SpainCLORAZEPATO NORMON 10 mg CAPSULAS DURAS EFGLaboratorios Normon S.A.
- CanadaCLORAZEPATEAA PHARMA INC
- FinlandAnxidinOrion Corporation Orion Pharma
- United KingdomTranxene 15mg capsulesBoehringer Ingelheim Ltd
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Belgium · Tranxene, Uni-Tranxene
- Spain · Clorazepato Normon, Tranxilium
- France · Tranxene
- Greece · Tranxene
- Italy · Transene
- Lithuania · Tranxene
- Luxembourg · Tranxene, Uni-Tranxene
- Netherlands · Tranxène, Tranxène Mb
- Poland · Cloranxen, Tranxene
- Portugal · Medipax, Tranxene
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a1170bf5-d6d1-4811-bbcc-922a901b2a25 GET /v1/drugs/a1170bf5-d6d1-4811-bbcc-922a901b2a25?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Dipotassium Clorazepate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about dipotassium clorazepate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.